Students and parent volunteers from a school in Washington State said in a lawsuit that they had become sick after being exposed to chemicals known as PCBs that had dripped from light fixtures.
Matthew Perry’s death was attributed to the effects of high levels of the anesthetic drug, which is increasingly used to treat depression.
Two physicians respond to a front-page article. Also: The children in Gaza; reviving local news; a divide in texting.
Hair-loss influencers on TikTok say they are destigmatizing a common insecurity. Critics say they are cashing in on a vulnerable audience.
Pediatricians are hesitating to prescribe medicines like Wegovy, citing their newness and uncertainties around them.
A guide to the different types of medications for treating insomnia, their risks and when experts recommend using them.
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit its reach.
A few simple solutions could save lives and ease the struggles of countless Americans.
Juries recently awarded plaintiffs more than $2 billion in damages tied to Roundup, the weedkiller that has been linked to cancer. Bayer is fighting back.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.